Failure patterns of locoregional recurrence in women with T1-2N1 breast cancer after modified radical mastectomy

X. Zhao, Shulian Wang, Yong-wen Song, Yu Tang, Yong Yang, H. Fang, Jianyang Wang, H. Jing, Jiang-hu Zhang, G. Sun, Siye Chen, J. Jin, Yueping Liu, Bo Chen, S. Qi, Ning Li, Yuan Tang, N. Lu
{"title":"Failure patterns of locoregional recurrence in women with T1-2N1 breast cancer after modified radical mastectomy","authors":"X. Zhao, Shulian Wang, Yong-wen Song, Yu Tang, Yong Yang, H. Fang, Jianyang Wang, H. Jing, Jiang-hu Zhang, G. Sun, Siye Chen, J. Jin, Yueping Liu, Bo Chen, S. Qi, Ning Li, Yuan Tang, N. Lu","doi":"10.3760/CMA.J.ISSN.1004-4221.2020.01.007","DOIUrl":null,"url":null,"abstract":"Objective \nTo analyze the failure patterns of locoregional recurrence (LRR) and investigate the range of radiotherapy in T1-2N1 breast cancer patients undergoing modified radical mastectomy. \n \n \nMethods \nFrom September 1997 to April 2015, 2472 women with T1-2N1 breast cancer after modified radical mastectomy without neoadjuvant systemic therapy were treated in our hospital. 1898 patients who did not undergo adjuvant radiotherapy were included in this study. The distribution of accumulated LRR was analyzed. The LR and RR rates were estimated by the Kaplan-Meier method, and the prognostic factors were identified in univariate analyses with Log-rank test. Multivariate analysis was performed using Cox logistic regression analysis. \n \n \nResults \nWith a median follow-up of 71.3 months (range 1.1-194.6), 164 patients had LRR, including supraclavicular/infraclavicular lymph nodes in 106(65%), chest wall in 69(42%), axilla in 39(24%) and internal mammary lymph nodes (IMNs) in 19 patients (12%). In multivariate analysis, age (>45 years vs.≤45 years), tumor location (other quadrants vs. inner quadrant), T stage (T1vs. T2), the number of positive axillary lymph nodes (1 vs. 2-3), hormone receptor status (positive vs. negative) were significant prognostic factors for both LR and RR. \n \n \nConclusions \nIn patients with T1-2N1 breast cancer after modified radical mastectomy, the most common LRR site is supraclavicular/infraclavicular nodal region, followed by chest wall. The axillary or IMN recurrence is rare. The prognostic factors for LR and RR are similar, which indicates that supraclavicular/infraclavicular and chest wall irradiation should be considered for postmastectomy radiotherapy. \n \n \nKey words: \nBreast neoplasm/modified radical mastectomy; Positive lymph node; Locoregional recurrence patterns","PeriodicalId":10288,"journal":{"name":"中华放射肿瘤学杂志","volume":"29 1","pages":"31-34"},"PeriodicalIF":0.0000,"publicationDate":"2020-01-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"中华放射肿瘤学杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1004-4221.2020.01.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objective To analyze the failure patterns of locoregional recurrence (LRR) and investigate the range of radiotherapy in T1-2N1 breast cancer patients undergoing modified radical mastectomy. Methods From September 1997 to April 2015, 2472 women with T1-2N1 breast cancer after modified radical mastectomy without neoadjuvant systemic therapy were treated in our hospital. 1898 patients who did not undergo adjuvant radiotherapy were included in this study. The distribution of accumulated LRR was analyzed. The LR and RR rates were estimated by the Kaplan-Meier method, and the prognostic factors were identified in univariate analyses with Log-rank test. Multivariate analysis was performed using Cox logistic regression analysis. Results With a median follow-up of 71.3 months (range 1.1-194.6), 164 patients had LRR, including supraclavicular/infraclavicular lymph nodes in 106(65%), chest wall in 69(42%), axilla in 39(24%) and internal mammary lymph nodes (IMNs) in 19 patients (12%). In multivariate analysis, age (>45 years vs.≤45 years), tumor location (other quadrants vs. inner quadrant), T stage (T1vs. T2), the number of positive axillary lymph nodes (1 vs. 2-3), hormone receptor status (positive vs. negative) were significant prognostic factors for both LR and RR. Conclusions In patients with T1-2N1 breast cancer after modified radical mastectomy, the most common LRR site is supraclavicular/infraclavicular nodal region, followed by chest wall. The axillary or IMN recurrence is rare. The prognostic factors for LR and RR are similar, which indicates that supraclavicular/infraclavicular and chest wall irradiation should be considered for postmastectomy radiotherapy. Key words: Breast neoplasm/modified radical mastectomy; Positive lymph node; Locoregional recurrence patterns
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
改良根治性乳房切除术后T1-2N1乳腺癌症局部复发的失败模式
目的分析改良根治性乳房切除术后T1-2N1乳腺癌局部复发(LRR)的失败模式及放疗范围。方法1997年9月至2015年4月,在我院对2472例癌症T1-2N1乳腺癌患者行改良根治性乳房切除术,无需新辅助系统治疗。1898名未接受辅助放射治疗的患者被纳入本研究。分析了累积LRR的分布。采用Kaplan-Meier方法估计LR和RR发生率,并采用Log-rank检验在单变量分析中确定预后因素。采用Cox逻辑回归分析进行多变量分析。结果164例患者中位随访71.3个月(1.1-194.6),其中锁骨上/锁骨下淋巴结106例(65%),胸壁69例(42%),腋窝39例(24%),乳内淋巴结19例(12%)。在多变量分析中,年龄(>45岁vs.≤45岁)、肿瘤位置(其他象限vs.内象限)、T分期(T1vs..T2)、腋窝淋巴结阳性数(1 vs.2-3)、激素受体状态(阳性vs.阴性)是LR和RR的重要预后因素。结论改良根治性乳房切除术后T1-2N1乳腺癌症患者最常见的LRR部位为锁骨上/锁骨下结区,其次为胸壁。腋窝或IMN复发是罕见的。LR和RR的预后因素相似,这表明应考虑锁骨上/锁骨下和胸壁照射进行骨切除术后放疗。关键词:乳腺肿瘤/改良根治性乳房切除术;阳性淋巴结;局部复发模式
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
6375
期刊介绍: The Chinese Journal of Radiation Oncology is a national academic journal sponsored by the Chinese Medical Association. It was founded in 1992 and the title was written by Chen Minzhang, the former Minister of Health. Its predecessor was the Chinese Journal of Radiation Oncology, which was founded in 1987. The journal is an authoritative journal in the field of radiation oncology in my country. It focuses on clinical tumor radiotherapy, tumor radiation physics, tumor radiation biology, and thermal therapy. Its main readers are middle and senior clinical doctors and scientific researchers. It is now a monthly journal with a large 16-page format and 80 pages of text. For many years, it has adhered to the principle of combining theory with practice and combining improvement with popularization. It now has columns such as monographs, head and neck tumors (monographs), chest tumors (monographs), abdominal tumors (monographs), physics, technology, biology (monographs), reviews, and investigations and research.
期刊最新文献
Current situation and research progress on postoperative adjuvant radiotherapy for thymoma Mechanism of radiation combined with recombinant human endostatin in inducing myocardial fibrosis The diagnostic value of HPV detection in squamous cell carcinoma of cervical lymph node metastasis from an unknown primary site (with report of 6 cases) Application of ArcCHECK system in the verification of tomotherapy plan for esophageal cancer Current situation of clinical research of buccal mucosa squamous cell carcinoma
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1